Biden is supporting the pharmaceutical industry in discussions for a global treaty during the pandemic.
The stance of the Biden administration in international discussions regarding the allocation of vaccines in future pandemics demonstrates that the president is not fully willing to disrupt the patent system. | Getty Images The Biden administration and pharmaceutical companies are engaged in a dispute regarding medication costs both in the nation’s capital and in courtrooms
READ MORE